Computational Modeling for Cardiovascular Devices; Public Workshop, 19097-19098 [E9-9474]
Download as PDF
<![CDATA[
Federal Register / Vol. 74, No. 79 / Monday, April 27, 2009 / Notices
‘‘guideline.’’ In addition, guidance
documents must not include mandatory
language such as ‘‘shall,’’ ‘‘must,’’
‘‘require,’’ or ‘‘requirement,’’ unless
FDA is using these words to describe a
statutory or regulatory requirement. The
guidance represents agency’s current
thinking on the topic. It does not create
or confer any rights for or on any person
and does not operate to bind FDA or the
public. An alternative approach may be
used if such approach satisfies the
requirements of applicable statutes and
regulations.
IV. Paperwork Reduction Act of 1995
This guidance refers to previously
approved collections of information
found in FDA regulations. These
collections of information are subject to
review by the Office of Management and
Budget (OMB) under the Paperwork
Reduction Act of 1995 (44 U.S.C. 3501–
3520). The collections of information in
sections 1–5 of the guidance have been
approved under OMB control no. 0910–
0032 (expiration date April 30, 2010).
V. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) written or electronic
comments regarding this document.
Submit a single copy of electronic
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified with the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
VI. Electronic Access
Persons with access to the Internet
may obtain the guidance at either https://
www.fda.gov/cvm or https://
www.regulations.gov.
Dated: April 20, 2009.
Jeffrey Shuren,
Associate Commissioner for Policy and
Planning.
[FR Doc. E9–9521 Filed 4–24–09; 8:45 am]
BILLING CODE 4160–01–S
Times and Dates:
8 a.m.–8:15 a.m., April 27, 2009 (Open).
8:15 a.m.–4 p.m., April 27, 2009 (Closed).
Place: Teleconference, Toll Free Number:
(877) 468–4185, Participant Pass code: 447–
5689.
Status: Portions of the meetings will be
closed to the public in accordance with
provisions set forth in Section 552b(c)(4) and
(6), Title 5, U.S.C., and the Determination of
the Director, Management Analysis and
Services Office, CDC, pursuant to Section
10(d) of Public Law 92–463.
Purpose: This group is charged with
providing advice and guidance to the
Secretary, Department of Health and Human
Services, and the Director, CDC, concerning
the scientific and technical merit of grant and
cooperative agreement applications received
from academic institutions and other public
and private profit and nonprofit
organizations, including State and local
government agencies, to conduct specific
injury research that focuses on prevention
and control.
Matters To Be Discussed: The meeting will
include the review, discussion, and
evaluation of applications submitted in
response to Fiscal Year 2009 Requests for
Applications related to the following
individual research announcement: CE09–
009, Youth Violence Prevention through
Economic, Environmental, and Policy
Change (U01).
Agenda items are subject to change as
priorities dictate.
Due to programmatic issues that had to be
resolved, the Federal Register notice is being
published less than fifteen days before the
date of the meeting.
Contact Person for More Information: Lisa
T. Garbarino, B.S., NCIPC, Extramural
Research Program Office, CDC, 4770 Buford
Highway, NE., M/S F62, Atlanta, Georgia
30341–3724, Telephone: (404) 723–1527.
The Director, Management Analysis and
Services Office has been delegated the
authority to sign Federal Register notices
pertaining to announcements of meetings and
other committee management activities for
both CDC and the Agency for Toxic
Substances and Disease Registry.
Dated: April 21, 2009.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. E9–9503 Filed 4–24–09; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
pwalker on PROD1PC71 with NOTICES
(Pub. L. 92–463), CDC announces the
following meeting of the
aforementioned review group:
BILLING CODE 4163–18–P
National Center for Injury Prevention
and Control, Initial Review Group,
(NCIPC, IRG)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
VerDate Nov<24>2008
15:55 Apr 24, 2009
Jkt 217001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
19097
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2009–N–0664]
Computational Modeling for
Cardiovascular Devices; Public
Workshop
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice of public workshop.
The Food and Drug Administration
(FDA) is announcing a public workshop
entitled ‘‘Computational Modeling for
Cardiovascular Devices.’’ FDA is cosponsoring the conference with the
National Heart, Blood and Lung
Institute of the National Institutes of
Health and the National Science
Foundation. The purpose of the public
workshop is to facilitate discussion
among FDA and other interested parties
on the use of computational modeling in
the design, development, and evaluation
of cardiovascular medical devices.
Date and Time: The public workshop
will be held on June 1 and 2, 2009, from
8 a.m. to 5 p.m.
Location: The public workshop will
be held at the Hilton Washington DC/
Rockville Executive Meeting Center,
1750 Rockville Pike, Rockville, MD
20852.
Contact Person: Donna R. Lochner,
Center for Devices and Radiological
Health (HFZ–450), Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850, 240–276–4043, email: donna.lochner@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Why Are We Holding This Public
Workshop?
The purpose of the public workshop
is to facilitate discussion among FDA
and other interested parties on the use
of computational modeling in
cardiovascular device design,
development, and evaluation.
II. What Are the Topics We Intend to
Address at the Public Workshop?
We hope to discuss a large number of
issues at the public workshop,
including, but not limited to:
• Multi-scale modeling.
• Imaging for cardiovascular device
modeling.
• Physiologic input data for
cardiovascular device modeling.
• Device-specific issues related to
modeling, including a focus on heart
valves, drug-eluting and bare metal
stents, endovascular stents, cardiac
rhythm management, and mechanical
and circulatory support devices.
E:\FR\FM\27APN1.SGM
27APN1
19098
Federal Register / Vol. 74, No. 79 / Monday, April 27, 2009 / Notices
• Regulatory issues with
implementation of computer modeling.
III. Is There a Fee and How Do I
Register for the Public Workshop?
There is a fee to attend the public
workshop to defray the costs of meals
provided and other expenses. The fee
for the public workshop is $250. The
registration process will be handled by
BL Seamon. BL Seamon has extensive
experience in planning, executing, and
organizing educational meetings.
Register online at https://
www.blseamon.com. Although the
facility is spacious, registration will be
on a first-come, first-served basis.
If you need special accommodations
due to a disability, please contact Donna
R. Lochner at least 7 days before the
public workshop.
IV. Where Can I Find Out More About
This Public Workshop?
Background information on the public
workshop, registration information, the
agenda, information about lodging, and
other relevant information will be
posted, as it becomes available, on the
Internet at https://www.fda.gov/cdrh/
dsma/workshop.html.
Dated: April 16, 2009.
Daniel G. Schultz,
Director, Center for Devices and Radiological
Health.
[FR Doc. E9–9474 Filed 4–27–09; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Part C Early Intervention Services
Grant
pwalker on PROD1PC71 with NOTICES
AGENCY: Health Resources and Services
Administration, HHS.
ACTION: Notice of Noncompetitive
Replacement Award to Joseph P.
Addabbo Family Health Center.
SUMMARY: The Health Resources and
Services Administration (HRSA) will be
transferring Ryan White HIV/AIDS Part
C Early Intervention Services Grant
funds (authorized by Title XXVI of the
Public Health Service Act) originally
awarded to Caritas Health Care, Inc., to
the Joseph P. Addabbo Family Health
Center in order to ensure continuity of
critical HIV medical care and treatment
services to clients in Jamaica/Southeast
Queens, Borough of Queens, New York
City, New York.
SUPPLEMENTARY INFORMATION:
VerDate Nov<24>2008
15:55 Apr 24, 2009
Jkt 217001
Former Grantee of Record: Caritas
Health Care, Inc.
Original Period of Grant Support: July
1, 2006, to June 30, 2011.
Replacement Awardee: Joseph P.
Addabbo Family Health Center.
Amount of Replacement Award:
$388,253.
Period of Replacement Award: The
period of support for the replacement
award is March 1, 2009, to March 31,
2010.
Authority: Section 2651 of the Public
Health Service Act, 42 U.S.C. 300ff–51.
CFDA Number: 93.918.
Justification for the Exception to
Competition: The former grantee, Caritas
Health Care, Inc., notified HRSA that it
would not continue providing services
after February 28, 2009, as it is ceasing
operations. It is critical that there be
continuity in the medical care and
treatment of approximately 430 lowincome patients with HIV/AIDS in the
original service area, Jamaica/Southeast
Queens, Borough of Queens, New York
City, in New York. The Joseph P.
Addabbo Family Health Center is
located in the same geographical area
previously served by Caritas Health
Care, Inc., is a current Part C grantee
with an established record of providing
critical HIV/AIDS care and treatment,
and has purchased the St. Dominic’s
Family Health Center facility, one of the
sites where the Ryan White services for
Caritas Health Care, Inc., were provided.
This temporary replacement award will
ensure that there is no disruption of
critical care and services to the service
population while the service area is recompeted.
This service area will be included in
the upcoming competition for the Part C
HIV Early Intervention Services
competing application process for
project periods starting April 1, 2010.
FOR FURTHER INFORMATION CONTACT:
Maria C. Rios, via e-mail
mrios@hrsa.gov, or via telephone, 301–
443–0493.
Dated: April 17, 2009.
Mary K. Wakefield,
Administrator.
[FR Doc. E9–9516 Filed 4–24–09; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
DEPARTMENT OF HOMELAND
SECURITY
U.S. Customs and Border Protection
Agency Information Collection
Activities: Application for Overflight
Program/Advance Notice for Aircraft
Landings
AGENCY: U.S. Customs and Border
Protection (CBP), Department of
Homeland Security.
ACTION: 60-day notice and request for
comments; extension of an existing
collection of information: 1651–0087.
SUMMARY: As part of its continuing effort
to reduce paperwork and respondent
burden, CBP invites the general public
and other Federal agencies to comment
on an information collection
requirement concerning the Application
for Overflight Program/Advance Notice
for Aircraft Landings. This request for
comment is being made pursuant to the
Paperwork Reduction Act of 1995 (Pub.
L. 104–13; 44 U.S.C. 3505(c)(2)).
DATES: Written comments should be
received on or before June 26, 2009, to
be assured of consideration.
ADDRESSES: Direct all written comments
to the U.S. Customs and Border
Protection, Attn.: Tracey Denning,
Office of Regulations and Rulings, 799
9th Street, NW., 7th Floor, Washington,
DC 20229–1177
FOR FURTHER INFORMATION CONTACT:
Requests for additional information
should be directed to U.S. Customs and
Border Protection, Attn.: Tracey
Denning, Office of Regulations and
Rulings, 799 9th Street, NW., 7th Floor,
Washington, DC 20229–1177, Tel. (202)
325–0265.
SUPPLEMENTARY INFORMATION: CBP
invites the general public and other
Federal agencies to comment on
proposed and/or continuing information
collections pursuant to the Paperwork
Reduction Act of 1995 (Pub. L. 104–13;
44 U.S.C. 3505(c)(2)). The comments
should address: (a) Whether the
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimates of the burden of the
collection of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; (d)
ways to minimize the burden including
the use of automated collection
techniques or the use of other forms of
information technology; and (e) the
annual costs burden to respondents or
record keepers from the collection of
information (a total capital/startup costs
E:\FR\FM\27APN1.SGM
27APN1
]]>Agencies
[Federal Register Volume 74, Number 79 (Monday, April 27, 2009)]
[Notices]
[Pages 19097-19098]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E9-9474]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2009-N-0664]
Computational Modeling for Cardiovascular Devices; Public
Workshop
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice of public workshop.
-----------------------------------------------------------------------
The Food and Drug Administration (FDA) is announcing a public
workshop entitled ``Computational Modeling for Cardiovascular
Devices.'' FDA is co-sponsoring the conference with the National Heart,
Blood and Lung Institute of the National Institutes of Health and the
National Science Foundation. The purpose of the public workshop is to
facilitate discussion among FDA and other interested parties on the use
of computational modeling in the design, development, and evaluation of
cardiovascular medical devices.
Date and Time: The public workshop will be held on June 1 and 2,
2009, from 8 a.m. to 5 p.m.
Location: The public workshop will be held at the Hilton Washington
DC/Rockville Executive Meeting Center, 1750 Rockville Pike, Rockville,
MD 20852.
Contact Person: Donna R. Lochner, Center for Devices and
Radiological Health (HFZ-450), Food and Drug Administration, 9200
Corporate Blvd., Rockville, MD 20850, 240-276-4043, e-mail:
donna.lochner@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Why Are We Holding This Public Workshop?
The purpose of the public workshop is to facilitate discussion
among FDA and other interested parties on the use of computational
modeling in cardiovascular device design, development, and evaluation.
II. What Are the Topics We Intend to Address at the Public Workshop?
We hope to discuss a large number of issues at the public workshop,
including, but not limited to:
Multi-scale modeling.
Imaging for cardiovascular device modeling.
Physiologic input data for cardiovascular device modeling.
Device-specific issues related to modeling, including a
focus on heart valves, drug-eluting and bare metal stents, endovascular
stents, cardiac rhythm management, and mechanical and circulatory
support devices.
[[Page 19098]]
Regulatory issues with implementation of computer
modeling.
III. Is There a Fee and How Do I Register for the Public Workshop?
There is a fee to attend the public workshop to defray the costs of
meals provided and other expenses. The fee for the public workshop is
$250. The registration process will be handled by BL Seamon. BL Seamon
has extensive experience in planning, executing, and organizing
educational meetings. Register online at https://www.blseamon.com.
Although the facility is spacious, registration will be on a first-
come, first-served basis.
If you need special accommodations due to a disability, please
contact Donna R. Lochner at least 7 days before the public workshop.
IV. Where Can I Find Out More About This Public Workshop?
Background information on the public workshop, registration
information, the agenda, information about lodging, and other relevant
information will be posted, as it becomes available, on the Internet at
https://www.fda.gov/cdrh/dsma/workshop.html.
Dated: April 16, 2009.
Daniel G. Schultz,
Director, Center for Devices and Radiological Health.
[FR Doc. E9-9474 Filed 4-27-09; 8:45 am]
BILLING CODE 4160-01-S
